ストックスクリーナーアプリを入手
2.83
4.81%
0.13
アフターアワーズ：
2.90
0.07
+2.47%
前日終値:
$2.70
開ける：
$2.74
24時間の取引高:
6.32M
Relative Volume:
2.70
時価総額：
$102.96M
収益：
-
当期純損益:
$-10.58M
株価収益率:
-2.3583
EPS:
-1.2
ネットキャッシュフロー:
$-9.21M
1週間 パフォーマンス:
+11.42%
1か月 パフォーマンス:
+5.20%
6か月 パフォーマンス:
+191.15%
1年 パフォーマンス:
+177.45%
1日の値動き範囲:
$2.69
$3.05
1週間の範囲:
$2.47
$3.05
52週間の値動き範囲:
$0.82
$3.38
Microbot Medical Inc Stock (MBOT) Company Profile
名前
Microbot Medical Inc
セクター
電話
908-938-5561
住所
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
MBOT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.83 | 92.40M | 0 | -10.58M | -9.21M | -1.20 |
|
ISRG
Intuitive Surgical Inc
|
552.41 | 196.08B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
173.01 | 49.62B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.38 | 43.30B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.76 | 36.04B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
80.12 | 15.87B | 3.93B | 415.40M | 384.70M | 2.06 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-01-13 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-01-31 | 開始されました | Ladenburg Thalmann | Buy |
Microbot Medical Inc (MBOT) 最新ニュース
Microbot Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Microbot Medical (MBOT) Projected to Post Earnings on Wednesday - Defense World
Renaissance Technologies LLC Takes $118,000 Position in Microbot Medical Inc. (NASDAQ:MBOT) - Defense World
Head to Head Survey: Microbot Medical (NASDAQ:MBOT) versus Hypertension Diagnostics (OTCMKTS:HDII) - Defense World
Geode Capital Management LLC Grows Stock Holdings in Microbot Medical Inc. (NASDAQ:MBOT) - Defense World
Cytosorbents (NASDAQ:CTSO) versus Microbot Medical (NASDAQ:MBOT) Financial Analysis - Defense World
Microbot Medical Releases Updated Presentation Materials - TipRanks
Microbot Medical regains Nasdaq compliance with bid price - MSN
Microbot Medical bolsters leadership ahead of FDA decision By Investing.com - Investing.com South Africa
Microbot Medical® Bolsters Commercial Leadership Team with the A - GuruFocus
Microbot Medical (MBOT) Strengthens U.S. Leadership Ahead of FDA Decision | MBOT Stock News - GuruFocus
Microbot Medical Strengthens Leadership Ahead of LIBERTY Launch - TipRanks
Microbot Medical bolsters leadership ahead of FDA decision - Investing.com
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers | MBOT Stock News - GuruFocus
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers - GlobeNewswire
Microbot Medical Accelerates FDA Launch Plans: Marketing VP with 15-Year Track Record Leads Commercial Push - Stock Titan
Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts? - Insider Monkey
10 Best Rising Penny Stocks to Buy According to Analysts - Insider Monkey
Microbot Medical announces proxy statement for annual meeting By Investing.com - Investing.com South Africa
Microbot Medical announces proxy statement for annual meeting - Investing.com
Microbot Medical modifies shareholder meeting quorum By Investing.com - Investing.com Canada
Microbot’s Liberty Boosts Stock: What’s Next? - timothysykes.com
Microbot Medical modifies shareholder meeting quorum - Investing.com
Global Robotic Exoskeleton Market Size Expected to Reach $30 Billion By 2032 as A.I. Influence Disrupts the Industry - GlobeNewswire
HC Wainwright Raises Earnings Estimates for Microbot Medical - Defense World
Microbot Medical's (MBOT) Robotic System Achieves Key Trial Succ - GuruFocus
HC Wainwright Reiterates Buy Rating for Microbot Medical (NASDAQ:MBOT) - Defense World
Microbot Medical clears pivotal study for remote-controlled endovascular procedures - Fierce Biotech
H.C. Wainwright maintains $9 target on Microbot Medical stock By Investing.com - Investing.com South Africa
Microbot Medical (MBOT) Awaits FDA Decision on LIBERTY® Robot - GuruFocus
Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader - Yahoo Finance
H.C. Wainwright maintains $9 target on Microbot Medical stock - Investing.com
Microbot Medical reports successful robotic trial By Investing.com - Investing.com Canada
Microbot Medical® Shares Results from Its Pivotal Clinical Trial - GuruFocus
Microbot Medical Data Backs Liberty Endovascular Surgical Robot - Medical Product Outsourcing
Sector Update: Health Care Stocks Rise Wednesday Afternoon - TradingView
Sector Update: Health Care - marketscreener.com
Microbot Medical (MBOT) Appoints Paul Mullen as VP of Sales - GuruFocus
Microbot Medical (MBOT) Advances Telesurgery with LIBERTY® Syste - GuruFocus
Microbot Medical (MBOT) Secures $13 Million Through Direct Offering - GuruFocus
Microbot Medical shares results from ACCESS-PVI pivotal trial - Vascular News
Microbot Medical Feels a Strong Surge Again? - timothysykes.com
Microbot Medical (MBOT) Unveils Promising Trial Data for LIBERTY System - GuruFocus
Microbot Medical (MBOT) Surges on Successful Trial Results - GuruFocus
Microbot Medical Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the Liberty® Endovascular Robotic System - MarketScreener
Microbot Medical reports successful robotic trial - Investing.com
Microbot Medical Says Study Shows Endovascular Robotic System Feasible - MarketScreener
Microbot Medical Inc (MBOT) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.94%
大文字化:
|
ボリューム (24 時間):